Robotics Adoption Leverage Meril's Mizzo Endo 4000 and surgical training simulator to drive hospital-level robotics programs; target centers expanding robotic capabilities and formal training partnerships, with bundled hardware, training services, and service support to encourage broader adoption.

TEER Growth Capitalize on MyClip TEER system for Mitral Regurgitation and positive LANDMARK trial outcomes to target major cardiac centers; offer comprehensive TEER solutions including devices, imaging support, training, and post-procedure service; pursue multi-site contracts with health systems expanding structural heart programs.

Manufacturing Scale Meril's substantial manufacturing expansion in Vapi and new plants creates opportunities for local sourcing, faster lead times, and potential contract manufacturing partnerships; position as a regional supplier of cardiac and surgical devices with robust quality and regulatory compliance to hospitals and distributors in India and neighboring markets.

Capital Backing Strong financial backing from strategic investors enables multi-year procurement commitments, rapid product rollouts, and bundled service agreements; approach large hospital groups and regional distributors with long-term supply contracts, service, and training packages that align with multi-year budgets.

Global Footprint Meril's international presence through Meril GmbH, global R&D, and high-profile industry events provides a platform to pursue cross-border sales, regulatory readiness, and international distribution partnerships; leverage overseas partnerships to enter European and Middle Eastern markets with integrated after-sales and training networks.